ISTH Congress Abstracts

Official abstracts site for the ISTH Congress

MENU 
  • Home
  • Congress Archive
    • ISTH 2020 Congress
  • Resources
  • Search

ISTH 2020 Congress

Platelet Disorders and von Willebrand Disease » VWF and von Willebrand Factor Disorders - Clinical Conditions

Theme Navigation

  • ISTH 2020 Congress
    • Platelet Disorders and von Willebrand Disease
      • VWF and von Willebrand Factor Disorders - Clinical Conditions

Abstract Number: PB1551

A Retrospective Study to Evaluate the Efficacy and Safety of a Plasma-Derived, von Willebrand Factor-Containing FVIII Concentrate, in Patients with Von Willebrand Disease (VWD) in Spain: Interim Analysis Results

V. Jiménez-Yuste1, R. Mir2

Abstract Number: PB1583

Acquired von-Willebrand-Disease (aVWD) in ECMO Patients: a 3-Year Cohort Study

T. Bajorat1, B. Panholzer2, A. Haneya2, D. Kowalski1, D. Juhl3, A. Rocke1, M. Shneyder1, P.M. Kuta1, H. Clausnizer1, U. Nowak-Göttl1

Abstract Number: PB1570

Adolescent Menorrhagia and Von Willebrand Disease

Y. Ouarhlent, M.R. Makhloufi

Abstract Number: PB1548

Characterization of Type 2B VWD in the US Zimmerman Program

P. Christopherson, V. Flood, S. Haberichter, T. Slobodianuk, P. Morateck, R. Montgomery, Zimmerman Program Investigators

Abstract Number: PB1561

Clinical and Phenotypic Evaluation of Patients with Low von Willebrand Factor

O. Seidi Zadeh, M. Ahmadinejad, M. Mojtabavi, S. Homayoun

Abstract Number: PB1538

Clinical Presentation of Von Willebrand Disease in a Developing Country-A Cross Sectional Study

A. Fatima

Abstract Number: PB1557

Clinically Relevant Differences between Two New Generation VWF: GPIbR Assays in a Patient with Acquired von Willebrand Syndrome – Case Report

K. Mayger1,2, A. McCormick1,2, S. Austin2

Abstract Number: PB1580

Comparison of von Willebrand Factor (VWF) Multimeric Profile Obtained by a Commercial Electrophoretic Test (Hydragel 5 von Willebrand Multimers) and Classical Home-made with a Discontinuous 1% Agarose Gel Electrophoresis

M.S. López1,2, J. Paiva3, A.I. Woods4, M.S. Saez1,2, L.H. Barrera1,5, V. Privitera6, F. Chuliber6, M. Villagra Iturre6, D. Penchasky6, P. Sorroche1,2, J. Oyhamburu1,2, M. Martinuzzo1,2, A. Sánchez Luceros3,4

Abstract Number: PB1582

Degradation of High Molecular Weight von Willebrand Factor Multimers during Extracorporeal Membrane Oxygenation-Treatment

M.-S. Kim1, C.-J. Park1, S. Jang1, Y.-U. Cho1, S.-B. Hong2

Abstract Number: PB1579

Desmopressin in Patients with Type 2B von Willebrand Disease: Differential Impact on VWF and Platelet Function

A. Dupont1,2, A. Rauch1,2, C. Paris1,2, F. Lassalle1,2, A. Hochart1,2, B. Wibaut1,2, A. Bauters1,2, J. Goudemand1,2, C. Zawadzki1,2, E. Jeanpierre1,2, S. Susen1,2

Abstract Number: PB1590

Diagnosis and Management of von Willebrand Disease in a Portuguese Reference Center of Congenital Coagulopathies

C. Catarino Oliveira1, F. Rodrigues1, A. Pereira1, S. Campaniço1, M. Teodoro1, C. Silva Pinto2, P. Martinho2, T. Fidalgo2

Abstract Number: PB1589

Diagnostic Performances Evaluation of LIAPHEN vWF: Ag on CS-2500

C. Dunois1, P. Gueret2, R. Parage2, A. Pontis2, F. Nedelec2, I. Gouin2, J. Amiral1

Abstract Number: PB1574

Establishing Reference Intervals for von Willebrand Factor Multimers

M. Pikta1,2, M. Vasse3, S. Lejniece4,5, K.J. Smock6,7, K.A. Moser6,7, H. Bautista8, G. Nouadje8, V. Banys9

Abstract Number: PB1565

Evaluation of Carriers of Type 3 von Willebrand Disease with PFA200

T. Geevar1, R. Gautam Dave1, S. Singh1, R. V1, F. N A2, A. Srivastava2, S. C Nair1

Abstract Number: PB1572

Gastrointestinal Bleeding from Angiodysplasia in Constitutional von Willebrand Disease: Improved Diagnosis Yield and Risk Stratification when Using Video Capsule on Top of Conventional Endoscopy

A. Rauch1,2, C. Paris1, Y. Repesse3, J. Branche4, R. Gerard4, R. D'Oiron5, A. Harroche6, C. Ternisien7, S. Castet8, A. Lebreton9, B. Pan-Petesch10, F. Volot11, S. Clayssens12, P. Chamouni13, V. Gay14, A. Veyradier15, J. Goudemand1, S. Susen1,2

Abstract Number: OC 13.2

Genetic Analyses in 391 VWD Patients: Novel VWF Gene Variations, and Important Differences in the Phenotype of Type 1 VWD Patients with- and without – a VWF Gene Mutation

F. Atiq1, W.L. van Heerde2, J. Boender1, M.H. Cnossen3, B.A.P. Laros-van Gorkom2, J. de Meris4, K. Fijnvandraat5,6, S. Schoormans2, J.G. van der Bom7,8, K. Meijer9, K.P.M. van Galen10, J. Eikenboom11,12, F.W.G. Leebeek1, WiN Study Group

Abstract Number: PB1595

Gum Bleeding in Low Von Willebrand Factor- What’s the Score?

A. Dougall1,2, L. Parkinson3, S. Anishchuk1, M. Nolan2, K. Ryan2, N. O'Connell2, M. Lavin4, J. O'Donnell4, B. Daly1

Abstract Number: PB1581

Gynaecological Problems, Management and Outcomes in Women with Moderate and Severe von Willebrand Disease (VWD)

O. Turan, A. Epstein, D. Pollard, R. Abdul-Kadir

Abstract Number: PB1547

Harnessing Social Media to Improve Awareness of Bleeding Disorders

F. Alaya1, N. Costelloe2, B. O'Mahony3, J.M. O'Sullivan2, J.S. O'Donnell2,4, M. Lavin2,5

Abstract Number: PB1577

High Variability of Laboratory Phenotype in Genetically Proven von Willebrand Disease Type 2B

S. Bierkaemper1, K. Trautmann-Grill2, S. Marten2, O. Tiebel3, R. Knoefler1

  • 1
  • 2
  • 3
  • Next Page »

« View all themes from the ISTH 2020 Congress

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2021 John Wiley & Sons, Inc. All Rights Reserved.
Wiley
This site uses cookies: Find out more.